{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:47:21Z","timestamp":1793879241767,"version":"4.7.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T00:00:00Z","timestamp":1522713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13048-018-0400-5","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:25:02Z","timestamp":1522801502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study"],"prefix":"10.1186","volume":"11","author":[{"given":"Sarwat","family":"Jahan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abira","family":"Abid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Qurat-Ul-Ain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazala","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Almajwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Razak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,3]]},"reference":[{"issue":"6","key":"400_CR1","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis 1. Endocr Rev. 1997;18(6):774\u2013800.","journal-title":"Endocr Rev"},{"issue":"1","key":"400_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"E Rotterdam","year":"2004","unstructured":"Rotterdam E. ASRM-sponsored P: revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (Oxford, England). 2004;19(1):41.","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"13","key":"400_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333(13):853\u201361.","journal-title":"N Engl J Med"},{"issue":"3","key":"400_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/er.2005-0005","volume":"26","author":"T Kadowaki","year":"2005","unstructured":"Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439\u201351.","journal-title":"Endocr Rev"},{"issue":"9","key":"400_CR5","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1093\/humrep\/del146","volume":"21","author":"H Escobar-Morreale","year":"2006","unstructured":"Escobar-Morreale H, Villuendas G, Botella-Carretero J, Alvarez-Blasco F, Sanchon R, Luque-Ramirez M, San Millan J. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod. 2006;21(9):2257\u201365.","journal-title":"Hum Reprod"},{"key":"400_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","volume":"26","author":"A Gambineri","year":"2002","unstructured":"Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes. 2002;26:883.","journal-title":"Int J Obes"},{"issue":"6","key":"400_CR7","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774\u2013800.","journal-title":"Endocr Rev"},{"issue":"12","key":"400_CR8","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, Welt CK. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565\u201392.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"400_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/2042018810380215","volume":"1","author":"H Lashen","year":"2010","unstructured":"Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv in Endocrinol Metab. 2010;1(3):117\u201328.","journal-title":"Ther Adv in Endocrinol Metab"},{"issue":"1","key":"400_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/humrep\/deh588","volume":"20","author":"D Cibula","year":"2005","unstructured":"Cibula D, Fanta M, Vrbikova J, Stanicka S, Dvorakova K, Hill M, Skrha J, Zivny J, Skrenkova J. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. Hum Reprod. 2005;20(1):180\u20134.","journal-title":"Hum Reprod"},{"issue":"1","key":"400_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","volume":"30","author":"S Palomba","year":"2009","unstructured":"Palomba S, Falbo A, Zullo F, Orio JF. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1\u201350.","journal-title":"Endocr Rev"},{"issue":"1","key":"400_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0015-0282(03)00571-5","volume":"80","author":"V Fenkci","year":"2003","unstructured":"Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003;80(1):123\u20137.","journal-title":"Fertil Steril"},{"issue":"4","key":"400_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000113046","volume":"65","author":"FF Verit","year":"2008","unstructured":"Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Investig. 2008;65(4):233\u20139.","journal-title":"Gynecol Obstet Investig"},{"issue":"3","key":"400_CR14","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/0002-9343(91)90281-2","volume":"91","author":"H Sies","year":"1991","unstructured":"Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91(3):S31\u20138.","journal-title":"Am J Med"},{"issue":"1","key":"400_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1477-7827-3-28","volume":"3","author":"A Agarwal","year":"2005","unstructured":"Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3(1):28.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"400_CR16","first-page":"109","volume":"4","author":"BN Desai","year":"2012","unstructured":"Desai BN, Maharjan RH, Nampoothiri LP. Aloe barbadensis mill. Formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model. Pharm Res. 2012;4(2):109.","journal-title":"Pharm Res"},{"issue":"2","key":"400_CR17","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/ptr.2900","volume":"24","author":"P Grant","year":"2010","unstructured":"Grant P. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res. 2010;24(2):186\u20138.","journal-title":"Phytother Res"},{"key":"400_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13048-016-0295-y","volume":"9","author":"S Jahan","year":"2016","unstructured":"Jahan S, Munir F, Razak S, Mehboob A, Ain QU, Ullah H, Afsar T, Shaheen G, Almajwal A. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats. J Ovarian Res. 2016;9:86.","journal-title":"J Ovarian Res"},{"issue":"3","key":"400_CR19","first-page":"173","volume":"6","author":"P Moutsatsou","year":"2007","unstructured":"Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Horm-athens. 2007;6(3):173.","journal-title":"Horm-athens"},{"issue":"11","key":"400_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.lfs.2010.07.004","volume":"87","author":"C Chen","year":"2010","unstructured":"Chen C, Zhou J, Ji C. Quercetin: a potential drug to reverse multidrug resistance. Life Sci. 2010;87(11):333\u20138.","journal-title":"Life Sci"},{"issue":"2-3","key":"400_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejphar.2008.03.008","volume":"585","author":"AW Boots","year":"2008","unstructured":"Boots AW, Haenen GR, Bast A. Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol. 2008;585(2-3):325\u201337.","journal-title":"Eur J Pharmacol"},{"issue":"16","key":"400_CR22","first-page":"2994","volume":"33","author":"U Takahama","year":"1988","unstructured":"Takahama U. Scavenging of active oxygen by flavonoids. Tanpakushitsu kakusan koso Protein, nucleic acid, enzyme. 1988;33(16):2994.","journal-title":"Tanpakushitsu kakusan koso Protein, nucleic acid, enzyme"},{"issue":"21","key":"400_CR23","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0024-3205(99)00133-2","volume":"64","author":"F Shen","year":"1999","unstructured":"Shen F, Herenyiova M, Weber G. Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. Life Sci. 1999;64(21):1869\u201376.","journal-title":"Life Sci"},{"issue":"1","key":"400_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0952-3278(98)90125-9","volume":"58","author":"H Kim","year":"1998","unstructured":"Kim H, Mani I, Iversen L, Ziboh V. Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from Guinea-pigs. Prostaglandins Leukot Essent Fat Acids. 1998;58(1):17\u201324.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"1","key":"400_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0006-2952(02)01445-4","volume":"65","author":"A Wattel","year":"2003","unstructured":"Wattel A, Kamel S, Mentaverri R, Lorget F, Prouillet C, Petit J-P, Fardelonne P, Brazier M. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem Pharmacol. 2003;65(1):35\u201342.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"400_CR26","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1530-0277.2010.01238.x","volume":"34","author":"LC Leckey","year":"2010","unstructured":"Leckey LC, Garige M, Varatharajalu R, Gong M, Nagata T, Spurney CF, Lakshman RM. Quercetin and ethanol attenuate the progression of atherosclerotic plaques with concomitant up regulation of paraoxonase1 (PON1) gene expression and PON1 activity in LDLR\u2212\/\u2212 mice. Alcohol Clin Exp Res. 2010;34(9):1535\u201342.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"400_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.atherosclerosis.2011.04.023","volume":"218","author":"R Kleemann","year":"2011","unstructured":"Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY, Kooistra T. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis. 2011;218(1):44\u201352.","journal-title":"Atherosclerosis"},{"issue":"2","key":"400_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejphar.2011.02.022","volume":"658","author":"VA Kostyuk","year":"2011","unstructured":"Kostyuk VA, Potapovich AI, Suhan TO, de Luca C, Korkina LG. Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation. Eur J Pharmacol. 2011;658(2):248\u201356.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"400_CR29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3109\/13880209.2015.1091482","volume":"54","author":"KN Shah","year":"2016","unstructured":"Shah KN, Patel SS. Phosphatidylinositide 3-kinase inhibition: a new potential target for the treatment of polycystic ovarian syndrome. Pharm Biol. 2016;54(6):975\u201383.","journal-title":"Pharm Biol"},{"key":"400_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1126\/science.94.2449.545-a","volume":"94","author":"E Shorr","year":"1941","unstructured":"Shorr E. A new technic for staining vaginal smears: III, a single differential stain. Science. 1941;94:545\u20136.","journal-title":"Science"},{"issue":"12","key":"400_CR31","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1007\/BF03345661","volume":"31","author":"L Luo","year":"2008","unstructured":"Luo L, Huang J, Fu Y, Xu J, Qian Y. Effects of tea polyphenols on ovarian development in rats. J Endocrinol Investig. 2008;31(12):1110\u20138.","journal-title":"J Endocrinol Investig"},{"key":"400_CR32","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/S0076-6879(55)02300-8","volume":"2","author":"B Chance","year":"1955","unstructured":"Chance B, Maehly A. [136] assay of catalases and peroxidases. Methods Enzymol. 1955;2:764\u201375.","journal-title":"Methods Enzymol"},{"issue":"2","key":"400_CR33","first-page":"130","volume":"21","author":"P Kakkar","year":"1984","unstructured":"Kakkar P, Das B, Viswanathan P. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984;21(2):130\u20132.","journal-title":"Indian J Biochem Biophys"},{"key":"400_CR34","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/S0021-9258(19)41206-4","volume":"250","author":"I Carlberg","year":"1975","unstructured":"Carlberg I, Mannervik EB. Glutathione level in rat brain. J Biol Chem. 1975;250:4475\u201380.","journal-title":"J Biol Chem"},{"issue":"6","key":"400_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/13510002.1996.11747079","volume":"2","author":"M Iqbal","year":"1996","unstructured":"Iqbal M, Sharma S, Rezazadeh H, Hasan N, Abdulla M, Athar M. Glutathione metabolizing enzymes and oxidative stress in ferric nitrilotriacetate mediated hepatic injury. Redox Rep. 1996;2(6):385\u201391.","journal-title":"Redox Rep"},{"issue":"2","key":"400_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0003-9861(81)90095-3","volume":"206","author":"J Wright","year":"1981","unstructured":"Wright J, Colby H, Miles P. Cytosolic factors which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys. 1981;206(2):296\u2013304.","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"400_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1210\/en.2012-1693","volume":"154","author":"M Maliqueo","year":"2013","unstructured":"Maliqueo M, Sun M, Johansson J, Benrick A, Labrie F, Svensson H, L\u00f6nn M, Duleba AJ, Stener-Victorin E. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age. Endocrinology. 2013;154(1):434\u201345.","journal-title":"Endocrinology"},{"key":"400_CR38","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1093\/humrep\/dep049","volume":"24","author":"R Homburg","year":"2009","unstructured":"Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod. 2009;24:1548\u201355.","journal-title":"Hum Reprod"},{"issue":"2","key":"400_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.arcmed.2003.10.005","volume":"35","author":"H Kafali","year":"2004","unstructured":"Kafali H, Iriadam M, Ozardal\u0131 I, Demir N. Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res. 2004;35(2):103\u20138.","journal-title":"Arch Med Res"},{"issue":"4","key":"400_CR40","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.bbrc.2008.06.077","volume":"373","author":"J Ahn","year":"2008","unstructured":"Ahn J, Lee H, Kim S, Park J, Ha T. The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun. 2008;373(4):545\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"400_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bcp.2011.08.010","volume":"83","author":"M Russo","year":"2012","unstructured":"Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem Pharmacol. 2012;83(1):6\u201315.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"400_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2003.10.013","volume":"25","author":"P Dandona","year":"2004","unstructured":"Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4\u20137.","journal-title":"Trends Immunol"},{"issue":"5","key":"400_CR43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1177\/1933719116667218","volume":"24","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zhai D, Zhang D, Bai L, Yao R, Yu J, Cheng W, Yu C. Quercetin decreases insulin resistance in a polycystic ovary syndrome rat model by improving inflammatory microenvironment. Reprod sci. 2017;24(5):682\u201390.","journal-title":"Reprod sci"},{"issue":"2","key":"400_CR44","first-page":"115","volume":"49","author":"N Rezvan","year":"2017","unstructured":"Rezvan N, Moini A, Janani L, Mohammad K, Saedisomeolia A, Nourbakhsh M, Gorgani-Firuzjaee S, Mazaherioun M, Hosseinzadeh-Attar MJ. Effects of quercetin on adiponectin-mediated insulin sensitivity in polycystic ovary syndrome: a randomized placebo-controlled double-blind clinical trial. Horm Metab Res. 2017;49(2):115\u201321.","journal-title":"Horm Metab Res"},{"issue":"41","key":"400_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/0973-1296.149708","volume":"11","author":"HM Eid","year":"2015","unstructured":"Eid HM, Nachar A, Thong F, Sweeney G, Haddad PS. The molecular basis of the antidiabetic action of quercetin in cultured skeletal muscle cells and hepatocytes. Pharmacogn Mag. 2015;11(41):74\u201381.","journal-title":"Pharmacogn Mag"},{"issue":"3","key":"400_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4162\/nrp.2012.6.3.201","volume":"6","author":"SM Jeong","year":"2012","unstructured":"Jeong SM, Kang MJ, Choi HN, Kim JH, Kim JI. Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db\/db mice. Nutr res pract. 2012;6(3):201\u20137.","journal-title":"Nutr res pract"},{"issue":"2","key":"400_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2174\/157340410791321336","volume":"6","author":"J Yeon Lee","year":"2010","unstructured":"Yeon Lee J, Baw CK, Gupta S, Aziz N, Agarwal A. Role of oxidative stress in polycystic ovary syndrome. Current Women\u2019s Health Rev. 2010;6(2):96\u2013107.","journal-title":"Current Women\u2019s Health Rev"},{"issue":"3","key":"400_CR48","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bpobgyn.2010.10.016","volume":"25","author":"GJ Burton","year":"2011","unstructured":"Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstetrics Gynaecol. 2011;25(3):287\u201399.","journal-title":"Best Pract Res Clin Obstetrics Gynaecol"},{"issue":"6","key":"400_CR49","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1095\/biolreprod62.6.1745","volume":"62","author":"L Liu","year":"2000","unstructured":"Liu L, Trimarchi JR, Keefe DL. Involvement of mitochondria in oxidative stress-induced cell death in mouse zygotes. Biol Reprod. 2000;62(6):1745\u201353.","journal-title":"Biol Reprod"},{"issue":"1","key":"400_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1477-7827-10-49","volume":"10","author":"A Agarwal","year":"2012","unstructured":"Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10(1):49.","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"400_CR51","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1177\/0960327111426589","volume":"31","author":"M Rezvanfar","year":"2012","unstructured":"Rezvanfar M, Ahmadi A, Saadi HS, Baeeri M, Abdollahi M. Mechanistic links between oxidative\/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone. Hum Exp toxicol. 2012;31(9):887\u201397.","journal-title":"Hum Exp toxicol"},{"issue":"1","key":"400_CR52","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1210\/jc.2005-1696","volume":"91","author":"F Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):336\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"400_CR53","first-page":"722","volume":"52","author":"B Yildirim","year":"2007","unstructured":"Yildirim B, Demir S, Temur I, Erdemir R, Kaleli B. Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome during assisted reproduction cycles. J Reprod Med. 2007;52(8):722\u20136.","journal-title":"J Reprod Med"},{"issue":"3","key":"400_CR54","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","volume":"95","author":"RA Wild","year":"2011","unstructured":"Wild RA, Rizzo M, Clifton S, Carmina E. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073\u20139. e1011","journal-title":"Fertil Steril"},{"issue":"3","key":"400_CR55","first-page":"2013","volume":"9","author":"S Sasikala","year":"2009","unstructured":"Sasikala S, Shamila S. Unique rat model exhibiting biochemical fluctuations of letrozole induced polycystic ovary syndrome and subsequent treatment with allopathic and ayurvedic medicines. J Cell Tissue Res. 2009;9(3):2013.","journal-title":"J Cell Tissue Res"},{"issue":"12","key":"400_CR56","first-page":"54","volume":"9","author":"M Heibashy","year":"2013","unstructured":"Heibashy M, Mazen G, Shahin M. Metabolic changes and hormonal disturbances in polycystic ovarian syndrome rats and the amelioration effects of metformin and\/or cinnamon extraction. J Am Sci. 2013;9(12):54\u2013p62.","journal-title":"J Am Sci"},{"issue":"5","key":"400_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1590\/S0100-879X2004000500015","volume":"37","author":"H Mendon\u00e7a","year":"2004","unstructured":"Mendon\u00e7a H, Montenegro Junior R, Foss M, Silva de S\u00e1 M, Ferriani R. Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome. Braz J Med Biol Res. 2004;37(5):729\u201336.","journal-title":"Braz J Med Biol Res"},{"issue":"9","key":"400_CR58","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1093\/humrep\/dei093","volume":"20","author":"SA Doi","year":"2005","unstructured":"Doi SA, Al-Zaid M, Towers PA, Scott CJ, Al-Shoumer KA. Irregular cycles and steroid hormones in polycystic ovary syndrome. Hum Reprod. 2005;20(9):2402\u20138.","journal-title":"Hum Reprod"},{"issue":"1","key":"400_CR59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1757-2215-2-17","volume":"2","author":"S Fukuda","year":"2009","unstructured":"Fukuda S, Orisaka M, Tajima K, Hattori K, Kotsuji F. Luteinizing hormone-induced Akt phosphorylation and androgen production are modulated by MAP kinase in bovine theca cells. J Ovarian Res. 2009;2(1):17.","journal-title":"J Ovarian Res"},{"issue":"4","key":"400_CR60","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1210\/endo-111-4-1201","volume":"111","author":"K BOGOVICH","year":"1982","unstructured":"BOGOVICH K, RICHARDS JS. Androgen biosynthesis in developing ovarian follicles evidence that luteinizing hormone regulates thecal 17\u03b1-hydroxylase and C17\u20132o-Lyase activities. Endocrinology. 1982;111(4):1201\u20138.","journal-title":"Endocrinology"},{"issue":"3","key":"400_CR61","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1210\/jc.2004-1860","volume":"90","author":"JK Wickenheisser","year":"2005","unstructured":"Wickenheisser JK, Nelson-DeGrave VL, McAllister JM. Dysregulation of cytochrome P450 17\u03b1-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. Journal Clin Endocrinol Metab. 2005;90(3):1720\u20137.","journal-title":"Journal Clin Endocrinol Metab"},{"issue":"3","key":"400_CR62","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","volume":"28","author":"S Palomba","year":"2017","unstructured":"Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab. 2017;28(3):186\u201398.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"400_CR63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/er.2006-0022","volume":"28","author":"C Stocco","year":"2007","unstructured":"Stocco C, Telleria C, Gibori G. The molecular control of Corpus luteum formation, function, and regression. Endocr Rev. 2007;28(1):117\u201349.","journal-title":"Endocr Rev"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-018-0400-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-018-0400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T20:03:27Z","timestamp":1660766607000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-018-0400-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,3]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["400"],"URL":"https:\/\/doi.org\/10.1186\/s13048-018-0400-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,3]]},"assertion":[{"value":"17 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study makes use of rats and the experimental protocol for the use of animal was approved (BAS#0256) by the ethical board of Quaid-i-Azam University, Islamabad Pakistan.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"26"}}